About Al-Harmain Pharma (India) Private Limited
Data last updated:
Al-Harmain Pharma (India) Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 02 September 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2004PTC128769. Its GSTIN is 09AAECA8641C1ZT (Uttar Pradesh). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.62 Cr. It is led by directors Mohd Tariq and Saboor Ahmed Siddiqui.
Its last annual general meeting (AGM) was held on 27 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at L – 27 Second Floor Gali No – 9. Zakir Nagar Okhla, New Delhi, Delhi, India – 110025.
As per the financials filed for FY 2025, the company reported a revenue of ₹40 Lakh, a decline of 69% compared to the previous year. For the same year it recorded a net loss of ₹98.67 Lakh (net margin -246.6%) and EBITDA of -₹92.45 Lakh (EBITDA margin -231.1%). Revenue has declined at a compounded annual rate (CAGR) of 67% over three years and 49% over five years.
The company is associated with 1 brand: AL-Harmain Pharma. As per MCA filings, the company has open charges of ₹10.22 Lakh and satisfied charges of ₹2 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alharmainpharma.com.
Company details
Contact details
Al-Harmain Pharma (India) Private Limited's registered office is in New Delhi, Delhi. Its website is alharmainpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressL – 27 Second Floor Gali No – 9. Zakir Nagar Okhla, New Delhi, Delhi, India – 110025
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Al-Harmain Pharma (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Al-Harmain Pharma (India) operates one associated brand: AL-Harmain Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacture and distribution of Unani medicines in India. | alharmainpharma.in |
Business activity
The main business activity of Al-Harmain Pharma (India) is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Al-Harmain Pharma (India) Private Limited, buy the company report.
Financials of Al-Harmain Pharma (India) Private Limited
FY 2025 filings availableAl-Harmain Pharma (India) Private Limited reported revenue of ₹40 Lakh (down 69% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 49% over five years, including a 69% fall in the latest year. EBITDA fell 74% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹92.45 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹98.67 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -231.1% | ||||
| Net Profit Margin | -246.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Al-Harmain Pharma (India) Private Limited, buy the company report.
Board of directors of Al-Harmain Pharma (India) Private Limited
Al-Harmain Pharma (India) has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohd Tariq | Director | 02 Sep 2004 | 22 Years 2 Months | Current |
| Saboor Ahmed Siddiqui | Director | 02 Sep 2004 | 22 Years 2 Months | Current |
Auditor
Al-Harmain Pharma (India) Private Limited is audited by ASLAM JAVED & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASLAM JAVED & CO | FY 2020 | 016224N |
Shareholding
The shareholding of Al-Harmain Pharma (India) Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Al-Harmain Pharma (India) Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Aug 2022 | 100628159 | Hdfc Bank Limited | ₹4.13 Lakh | Open | |
| 01 Jul 2022 | 100873490 | Hdfc Bank Limited | ₹6.09 Lakh | Open | |
| 27 Nov 2019 | 100315004 | Others | ₹2 Cr | Satisfied |
To see the full charge records of Al-Harmain Pharma (India) Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Al-Harmain Pharma (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Al-Harmain Pharma (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Al-Harmain Pharma (India) has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECA8641C1ZT | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Al-Harmain Pharma (India) Private Limited, buy the company report.
Recent activity
Al-Harmain Pharma (India) Private Limited has 5 board changes on record since 2004: 3 appointments and 2 cessations. The latest: Shabana Akram ceased to be Director on 21 Dec 2021.
1 earlier event is in the company report.
Frequently asked questions
Al-Harmain Pharma (India) is an active private limited company based in New Delhi, Delhi, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 02 September 2004 (22+ years old) and is registered under CIN U24232DL2004PTC128769.
Al-Harmain Pharma (India) has 2 current directors:
- Mohd Tariq - Director
- Saboor Ahmed Siddiqui - Director
The latest financial statements of Al-Harmain Pharma (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 December 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Al-Harmain Pharma (India) is 09AAECA8641C1ZT, registered in Uttar Pradesh. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Al-Harmain Pharma (India) is U24232DL2004PTC128769. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Al-Harmain Pharma (India) was incorporated on 02 September 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.
Shabana Akram ceased to be Director on 21 Dec 2021. Mohammed Mohsin Siddiqui ceased to be Additional Director on 30 Sep 2021. Mohammed Mohsin Siddiqui was appointed as Director on 10 Jun 2021. Al-Harmain Pharma (India) has 5 board changes on record in total.
Al-Harmain Pharma (India) can be reached through the website alharmainpharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Al-Harmain Pharma (India) is at L – 27 Second Floor Gali No – 9. Zakir Nagar Okhla, New Delhi, Delhi, India – 110025.
Al-Harmain Pharma (India) operates in the healthcare industry, in the ayurvedic products and services segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
